MedTrace Logo

Evaluation of the Risk of VTE Among Patients Hospitalized in Non-surgical Departments

NCT03073915 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2018-06-12

No results posted yet for this study

Summary

Patients hospitalized in internal wards are at risk for VTE. The current guidelines recommend the use of thromboprophylaxis for 7-10 days among patients who are at increased risk for VTE. Yet several retrospective studies have shown that the compliance with this guideline is low. Physicians are often reluctant to administer LMWH to their fragile patients mainly because they are not convince that the risk associated with such therapy is greater than the risk for VTE.

In the current study, data concerning the use of thromboprophylaxis among patients admitted to the medical wards will be collected. The occurrence of bleeding or thrombotic event will be evaluated prospectively.

Conditions

  • Thromboembolism

Sponsors & Collaborators

  • Hadassah Medical Organization

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2020-12-31
Completion
2020-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03073915 on ClinicalTrials.gov